Screen of existing drugs finds compounds active against MERS coronavirus

Research by NIH scientists, grantees identifies leads for further study

2014-05-20

(Press-News.org) WHAT: Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS-CoV), a virus first detected in humans in 2012 that has since caused 614 laboratory-confirmed infections, including 181 that were fatal, according to the World Health Organization. The case count escalated sharply in the spring of this year, and the first cases in the United States were announced in early May. To address the urgent need for therapies, researchers supported by the National Institutes of Health screened a set of 290 compounds already approved by the U.S. Food and Drug Administration or far advanced in clinical development for other indications to determine if any might also show potential for working against MERS-CoV.

From the group of 290 compounds, the scientists identified 27 that, in test tube experiments, showed activity against both MERS-CoV and the related SARS coronavirus. These included compounds that inhibited the viruses' ability to enter and infect cells. The active compounds belong to 13 different classes of pharmaceuticals, including drugs normally used to treat cancer and psychiatric conditions, and provide leads for continued study in animals and potentially for study in people. The research team is now studying the effects of some of the identified compounds in mice experimentally infected with MERS-CoV.

"Given development times and manufacturing requirements for new products, repurposing of existing drugs is likely the only solution for outbreaks due to emerging viruses," the investigators noted in the paper now online in the journal Antimicrobial Agents and Chemotherapy. The research was a collaboration between investigators at the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, and Matthew B. Frieman, Ph.D., of the University of Maryland School of Medicine in Baltimore.

INFORMATION: ARTICLE: J Dyall et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy DOI: 10.1128/AAC.03036-14 (2014).

WHO: NIAID Director Anthony S. Fauci., M.D., is available to comment on this research. Co-author Lisa Hensley, Ph.D., associate director for science, NIAID Integrated Research Facility, is also available to discuss the findings.

CONTACT: To schedule interviews, please contact Anne A. Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov.

For additional information about research on MERS and other coronaviruses by NIAID scientists and grantees, see: http://www.niaid.nih.gov/topics/coronavirus/Pages/default.aspx.

The study was funded, in part, by NIAID grant AI095569.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov. About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.

NIH...Turning Discovery Into Health®

ELSE PRESS RELEASES FROM THIS DATE:

Detroit Lions help rebuild city with innovative gridiron giving, U-M researchers say

2014-05-20

ANN ARBOR—The Detroit Lions' new model of philanthropy and community engagement may prove to be a touchdown for the city of Detroit. A new case study of corporate social responsibility in sport by University of Michigan researchers uses the Lions as an exemplar of a professional sports team reinventing its charitable giving and community relations approach in hopes of making a bigger impact on the community. In 2012, the Lions created the "Living in the City" campaign—a new model of corporate philanthropy that emphasizes deeper relationships with a small core group ...

UofL researcher and team explore broader definition of successful aging

2014-05-20

LOUISVILLE, Ky. – An aging population poses challenges for governments around the globe as nations grapple with how to satisfy the physical, social and economic needs of older adults. About 126 million adults 65 years and older live in China - the country with the largest population of senior citizens, while 40 million adults 65 years and older live in the United States. In an article published today in Journal of Transcultural Nursing, University of Louisville School of Nursing assistant professor Valerie Lander McCarthy, PhD, RN; Ji Hong, MSN, a visiting scholar from ...

With climate changing, southern plants outperform northern

2014-05-20

Can plants and animals evolve to keep pace with climate change? A study published May 19 in the journal Proceedings of the National Academy of Sciences shows that for at least one widely-studied plant, the European climate is changing fast enough that strains from Southern Europe already grow better in the north than established local varieties. Small and fast-growing, Arabidopsis thaliana is widely used as the "lab mouse" of plant biology. The plant grows in Europe from Spain to Scandinavia and because Arabidopsis is so well-studied, there is a reference collection of ...

The added value of local food hubs

2014-05-20

(Santa Barbara, Calif.) — As the largest purchaser of wholesale produce in Santa Barbara County, UC Santa Barbara's residential dining services provided the perfect avenue for a pilot project incorporating local pesticide-free or certified organic produce into an institutional setting. The idea was conceived almost 10 years ago, when a group of students approached environmental studies professor David Cleveland about becoming a faculty adviser for student-led sustainable living classes. The group wanted to explore how to bring more local organic food in the dining halls. ...

Central Valley sees big drop in wintertime fog needed for fruit and nut crops

2014-05-20

BERKELEY — California's winter tule fog -- hated by drivers, but needed by fruit and nut trees -- has declined dramatically over the past three decades, raising a red flag for the state's multibillion dollar agricultural industry, according to researchers at the University of California, Berkeley. Crops such as almonds, pistachios, cherries, apricots and peaches go through a necessary winter dormant period brought on and maintained by colder temperatures. Tule fog, a thick ground fog that descends upon the state's Central Valley between late fall and early spring, helps ...

New analysis eliminates a potential speed bump in quantum computing

2014-05-20

A quantum particle can search for an item in an unsorted "database" by jumping from one item to another in superposition, and it does so faster than a classical computer ever could. This assertion assumes, however, that the particle can directly hop from any item to any other. Any restriction on which items the particle can directly hop to could slow down the search. "Intuition says that a symmetric database allows the particle to hop freely enough to retain the quantum speedup, but our research has shown this intuition to be false," says Tom Wong, a physicist at ...

Penn team identifies promising new target for gum disease treatment

2014-05-20

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications. University of Pennsylvania researchers have been searching for ways to prevent, half and reverse periodontitis. In a report published in the Journal of Immunology, they describe a promising new target: a component of the immune system called complement. Treating monkeys with a complement inhibitor successfully prevented the inflammation and bone loss that ...

A full serving of protein at each meal needed for maximum muscle health

2014-05-20

Most Americans eat a diet that consists of little to no protein for breakfast, a bit of protein at lunch and an overabundance of protein at dinner. As long as they get their recommended dietary allowance of about 60 grams, it's all good, right? Not according to new research from a team of scientists led by muscle metabolism expert Doug Paddon-Jones of the University of Texas Medical Branch at Galveston. This research shows that the typical cereal or carbohydrate-dominated breakfast, a sandwich or salad at lunch and overly large serving of meat/protein for dinner may not ...

Cognitive test can differentiate between Alzheimer's and normal aging

2014-05-20

CHAMPAIGN, Ill. — Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer's disease or the normal aging process. Their study appears in the journal Neuropsychologia. The Alzheimer's Association estimates that the number of Americans living with Alzheimer's disease will increase from 5 million in 2014 to as many as 16 million by 2050. Memory impairments and other early symptoms of Alzheimer's are often difficult to differentiate from the effects of normal aging, making it hard for doctors to ...

School-based interventions could benefit children from military families

2014-05-20

COLUMBIA, Mo. – Nearly 2 million children in the United States have experienced a parent's military deployment. Previous research has shown that these children may be at increased risk for emotional, behavioral and relationship difficulties, yet little is known about how best to address military children's specialized needs. Now, an MU researcher says school-based interventions could benefit children whose parents have deployed. David Albright, an assistant professor at the MU School of Social Work, says military children are an overlooked population in need ...

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

Screen of existing drugs finds compounds active against MERS coronavirus

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: